11/15/2021
Are You at Higher Genetic Risk of Prostate Cancer?
Are you worried about getting prostate cancer because of your family history? That’s a pretty good reason to be concerned: not to panic, but to be watchful – so..Read More
09/08/2021
At Last, Clarity!
John Strizver thought he was finished with prostate cancer 23 years ago, after a radical prostatectomy in 1998. And, for many years, he was: He and his wife, Janice,..Read More
08/23/2021
Olfactory Sensations! Meet the Dogs Leading the Revolution in Prostate Cancer Detection (Part 1)
Prostate cancer stinks. Figuratively and, well, literally. Humans can’t smell it, but dogs sure can. And get this: aggressive prostate cancer has its own smell, that dogs can distinguish! ..Read More
08/23/2021
Olfactory Sensations! Smells Like Cancer (Part 2)
Dogs with an excellent sense of smell can detect molecules in parts per trillion. Trillion! Hunting dogs, like Retrievers and Spaniels, and some working dog breeds, like German Shepherds..Read More
08/17/2021
Prostate MRI: “Way Far Ahead of the Game” (Part 3)
Prostate MRI’s ability to show what’s happening in the prostate is already transforming how prostate biopsies are done. Will it change treatment for prostate cancer, as well? Radiologist Peter Choyke,..Read More
08/12/2021
Prostate MRI: “Way Far Ahead of the Game” (Part 2)
Why is MRI on the upswing in prostate cancer? Because the information it provides is so good: it can show the size and location of tumors and guide a..Read More
08/05/2021
Prostate MRI: “Way Far Ahead of the Game” (Part 1)
Can MRI really make a difference in diagnosing prostate cancer? Just ask Robert Grey. It took nine years for his cancer to be diagnosed. He felt like a human..Read More
07/12/2021
Targeting PSMA: Serious Side Effects, and Navigating a Safe Course (Part 4)
EFFORTS TO REDUCE SIDE EFFECTS So, with all this published success, is there a downside to radioligands? Just like the use of magic in fairy tales – they come with..Read More
07/01/2021
Targeting PSMA: Dramatic Success (Part 3)
PCF-funded investigator Neil Bander, M.D., Director of Urological Oncology Research at Weill Cornell and a pioneer in the study of PSMA (prostate-specific membrane antigen), developed an antibody that targets..Read More
06/10/2021
Targeting PSMA: Making it Happen (Part 2)
PCF-funded investigator Neil Bander, M.D., Director of Urological Oncology Research at Weill Cornell and a pioneer in the study of PSMA, saw the potential of targeting PSMA, a molecule..Read More